Electronic Triggers: Messaging After A1C EHR Alert

Studying subjects with HbA1C tests >10 and no follow-up test within 6 months and appointments scheduled in the next 60 days from data run date. Subjects who receive intervention message may be more likely to follow up with their provider to schedule a follow up HbA1C test.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemoglobins Diagnostic Tests

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

NYU Langone Health

New York, 10016, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

MyChart active patients with HbA1C tests >10 and no follow-up test within 6 months and no appointments scheduled in the next 60 days from data run date

Exclusion criteria

Patients with a scheduled appointment within 60 days from time algorithm is run; hospital encounters; non English or Spanish patients as indicated by primary language in Epic

Treatment and study plan

MyChart message

Behavioral

Message subjects through MyChart to follow-up with their provider to schedule a follow up HbA1C test.

Primary outcomes

Rate of follow up A1C within 9 months after original A1C (allowing 3 months after email is sent)

Time frame: 2 years

This outcome measures the rate at which participants complete an A1C test within 3 months of the message intervention being sent and 9 months of their original test.

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Registry information

Important dates

Study start: 2020
Primary completion: 2024
Study completion: 2024
First posted: May 3, 2021
Registry last updated: Apr 10, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed